SCHEMBL1959768

SCHEMBL1959768

Nc1cc(=O)[nH]c(=S)n1CC1CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.73
KMT2A Q03164 3/20 0.73
CYP3A4 P08684 2/20 0.73
SMN1; SMN2 Q16637 2/20 0.73
MEN1 O00255 1/20 0.73
MTNR1A P48039 2/20 0.52
MTNR1B P49286 2/20 0.52
GAA P10253 3/20 0.45
MAPK1 P28482 1/20 0.45
HPGD P15428 2/20 0.41
PDE5A O76074 2/20 0.39
PDE4A P27815 2/20 0.39
PDE4B Q07343 2/20 0.39
PDE4C Q08493 2/20 0.39
PDE4D Q08499 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PLK1 P53350 1/20 0.37
TSHR P16473 3/20 0.36
MAPK10 P53779 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960103 0.92 KMT2A (0.63) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL1945404 0.85 ALDH1A1 (1.00) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL1959309 0.79 MPO (0.56) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL10735070 0.78 KMT2A (0.85) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL1958327 0.73 MTNR1A (0.52) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL1958324 0.71 GAA (0.59) ALDH1A1KMT2ASMN1; SMN2MEN1MTNR1A
SCHEMBL3059409 0.71 MTNR1A (0.50) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL562714 0.71 MTNR1A (0.57) ALDH1A1KMT2AMTNR1AMTNR1BGAA
SCHEMBL7026734 0.70 ALDH1A1 (0.56) ALDH1A1KMT2ACYP3A4SMN1; SMN2MEN1
SCHEMBL7187029 0.70 MTNR1A (0.56) ALDH1A1KMT2AMTNR1AMTNR1BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236951-B2 Thioxanthine derivatives as myeloperoxidase inhibitors ASTRAZENECA AB (SE) 2012-08-07 US disclosed
EP-1499613-B1 THIOXANTHINE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS ASTRAZENECA AB (SE) 2011-10-19 EP disclosed
EP-2332541-A1 Use of thioxanthine derivatives as MPO inhibitors AstraZeneca AB (SE) 2011-06-15 EP disclosed
US-20080293748-A1 Thioxanthine Derivatives as Myeloperoxidase Inhibitors ASTRAZENECA AB (SE) 2008-11-27 US disclosed
US-7425560-B2 Thioxanthine derivatives as myeloperoxidase inhibitors ASTRAZENECA AB (SE) 2008-09-16 US disclosed
US-20050234036-A1 Thioxanthine derivatives as myeloperoxidase inhibitors ASTRAZENECA AB (SE) 2005-10-20 US disclosed
EP-1499613-A1 THIOXANTHINE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS AstraZeneca AB (SE) 2005-01-26 EP disclosed
WO-2003089430-A1 THIOXANTHINE DERIVATIVES AS MYELOPEROXIDASE INHIBITORS ASTRAZENECA AB (SE) 2003-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293748-A1 Thioxanthine Derivatives as Myeloperoxidase Inhibitors MPO, XDH, EPX ALDH1A1 178/4885KMT2A 3549/4885CYP3A4 164/4885
US-20050234036-A1 Thioxanthine derivatives as myeloperoxidase inhibitors MPO, XDH, EPX ALDH1A1 178/4885KMT2A 3549/4885CYP3A4 164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.